Dasatinib Tablets

Product Description

Dasatinib Tablets

We are engaged in the wholesale, supply, and export of hygienically processed Dasatinib Sprycel used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) when other cancer treatments have not been effective. It slows the growth and spread of cancer cells in the body and blocks the action of abnormal proteins that signals the cancer cells to multiply.

Dasatinib, previously known as BMS-354825, is a cancer drug produced by Bristol-Myers Squibb and sold under the trade name Sprycel.

Features:

• Precise formulation
• Longer shelf life
• Processed as per the FDA standards

Specifications:

• Available in: 50 mg